1-3 of 3 results for subject:Insecticides
Librarians' tools
- Search time
- 0.152 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Insecticides
- We searched for
- subject_t:Insecticides OR subject_ses:91678
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask His Majesty's Government, further to the remarks by the Parliamentary Undersecretary for State for the Department for Environment, Food and Rural Affairs on 25 March (HC Deb col 924), what plans they have to raise awareness and improve pet owners' education with regards to using fipronil and imidacloprid.
To ask His Majesty's Government, further to the remarks by the Parliamentary Undersecretary for State for the Department for Environment, Food and Rural Affairs on 25 March (HC Deb col 924), what plans they have to raise awareness and improve pet owners' education with regards to using fipronil and imidacloprid.
The cross-Government Pharmaceuticals in the Environment (PiE) Group is convening a workshop in August 2025, focused on the environmental impact of pet parasiticides.
This event will bring together representatives from across the companion animal sector to share knowledge and expertise on this issue. The primary objective of the workshop is to collaboratively develop and agree on consistent messaging for pet owners regarding the appropriate use of topical parasiticides for cats and dogs. A key focus will be on how this messaging can be effectively disseminated across different settings - with the aim to minimise potential environmental impacts.
To ask His Majesty's Government, further to the Written Answer from Baroness Hayman of Ullock on 27 March 2025 (HL5886), whether they will publish the roadmap to address levels of fipronil or imidacloprid in UK waterways.
To ask His Majesty's Government, further to the Written Answer from Baroness Hayman of Ullock on 27 March 2025 (HL5886), whether they will publish the roadmap to address levels of fipronil or imidacloprid in UK waterways.
The roadmap to address levels of fipronil or imidacloprid in UK waterways will be published imminently, subject to ministerial clearance and upon receipt of a grid slot.
To ask His Majesty's Government what consideration they have given to restricting tick and flea treatments for pets containing fipronil or imidacloprid to prescription only, in the light of evidence of their human and environmental toxicity and their detrimental effects on aquatic life.
To ask His Majesty's Government what consideration they have given to restricting tick and flea treatments for pets containing fipronil or imidacloprid to prescription only, in the light of evidence of their human and environmental toxicity and their detrimental effects on aquatic life.
Parasiticides, such as those containing fipronil and imidacloprid, play an essential role in protecting both animal and human health against fleas and ticks and their associated vector-borne diseases, which can lead to parasitic disease in pets and present zoonotic risks to humans, as well as causing distress and discomfort. The concerns regarding the potential contribution of flea and tick treatments to the levels of imidacloprid currently being detected in UK surface waters are recognised. The Veterinary Medicine Directorate (VMD) is currently gathering evidence on this issue and has initiated the formation of a cross-governmental Pharmaceuticals in the Environment (PiE) Group.
The PiE Group has set out a roadmap of activities to address levels of fipronil and imidacloprid in UK waterways. The immediate priority is to collaborate with key stakeholders to enhance and promote consistent messaging to users on the appropriate use of topical parasiticides for cats and dogs, aiming to reduce potential environmental impacts. Beyond this, actions will focus on developing our evidence base through research and monitoring. The group will use this evidence to improve understanding of the issue and inform future policy activities in the longer term.
At this stage, there are no plans to restrict flea and tick treatments to prescription only. Any future regulatory decisions will be based on robust scientific evidence to ensure both environmental protection and continued access to essential veterinary medicines.